What actually happens at a genetic counselling appointment
A genetic counselling appointment can sound intimidating, particularly when you have already spent months learning medical words you never wanted in your vocabulary. In reality, it is usually a structured conversation about your personal and family history, the possibility of an inherited cancer risk, and whether genetic testing could provide useful information.
For Australian breast cancer survivors, the appointment may happen through a public genetics service, a private clinic, or via telehealth if you live outside a capital city. You are not expected to arrive with a perfect family tree or make a testing decision in the first ten minutes. The counsellor’s job is to explain your options in plain English, including the limits and possible emotional consequences of each one.
| Who you see | What they usually focus on | What you may leave with |
|---|---|---|
| Genetic counsellor | Family history, inherited risk, testing choices and emotional support | A risk assessment and an informed testing plan |
| Clinical geneticist | Medical assessment, complex diagnoses and specialist interpretation | Clinical recommendations and referrals |
| Oncologist or breast surgeon | Treatment, recurrence risk and whether testing may affect care | A referral or reason to consider genetic counselling |
| Commercial test provider | A packaged test and its reported findings | Results that may need independent clinical interpretation |
What the appointment is really for
Genetic counselling is not a pass-or-fail assessment of whether your cancer was “caused by genes”. It is a process for working out whether an inherited gene change could help explain your breast cancer or family pattern. Common genes discussed in hereditary breast cancer testing include BRCA1, BRCA2, PALB2, CHEK2, ATM and, in selected situations, TP53 and others.
Your counsellor may discuss whether the result could affect future screening, risk-reducing surgery, medication choices, or recommendations for relatives. If you have already finished active treatment, the information can still be relevant. It may influence surveillance for another cancer, help adult children understand their own risk, or explain why a particular testing pathway is being considered.
The discussion can also acknowledge the less tidy parts of survivorship. A medical appointment may bring up body image, family guilt, fear about children, or the frustration of discovering that your “cancer story” still has chapters left to write. Personal reflections, such as this candid account of radiation skin story, can remind survivors that the physical details of treatment deserve space too.
What to bring and what can wait
Before the appointment, write down the cancers affecting blood relatives on both sides of your family. Include the type of cancer, approximate age at diagnosis, and whether the person is living or has died. Your counsellor may ask about breast, ovarian, prostate, pancreatic, bowel and male breast cancers, along with unusual clusters or several cancers in one person.
Exact dates are helpful, but estimates are acceptable. You can ask relatives for information, check old funeral notices, or bring a rough family tree from your phone. If your family is small, relatives are adopted, or information is unavailable, say so. Those gaps are part of the assessment rather than evidence that you have prepared badly.
Bring pathology reports, treatment summaries or previous genetic results if you have them. In Australia, a referral from a GP, oncologist or breast surgeon may be needed for a public hospital genetics clinic, while private providers have their own arrangements. Waiting times can vary significantly between services in Sydney, Melbourne, Brisbane, Adelaide and Perth, and regional patients may be offered video appointments.
The conversation is more detailed than dramatic
The counsellor will usually begin by asking what brought you in and what you hope to learn. They may ask when you were diagnosed, the subtype of your breast cancer, whether it was bilateral or diagnosed at a younger age, and what treatments you received. If you have had tumour testing, they may explain how that differs from inherited, or germline, testing.
A family history is often drawn as a pedigree: circles, squares and lines representing relatives and relationships. It can feel strangely formal to see your family turned into symbols, but the diagram helps the counsellor notice patterns that are hard to spot in ordinary conversation. The appointment may also cover ancestry, because some inherited variants are more frequent in particular populations.
You should hear an explanation of benefits, limitations and possible outcomes before providing a sample. This is informed consent, not a box-ticking exercise. You can ask what the result might mean for your own care, who will receive it, how it will be stored, and whether you can decline testing after hearing the information.
How the test is chosen
If testing is appropriate, the sample is commonly blood or saliva. The laboratory may test one gene, a small group of genes, or a broader hereditary cancer panel. The choice depends on your diagnosis, family history, previous tumour findings and the clinical question being asked. A bigger panel does not automatically produce a more useful answer; it can also uncover findings that are difficult to interpret.
If possible, testing often starts with a relative who has had cancer, because a clear family result makes follow-up testing easier for unaffected relatives. When that person is unavailable, an affected survivor may be the best person to test. Your counsellor will explain the practical and emotional reasons for the proposed order.
You may hear three important result categories. A pathogenic or likely pathogenic variant is a harmful inherited change that can alter risk management. A negative result means no relevant change was found in the genes examined, but it may not erase a strong family history. A variant of uncertain significance, or VUS, is a change whose meaning is not yet known and generally should not be used alone to make major medical decisions.
This is also the point to be wary of social media certainty. A blog post claiming a food, supplement or household remedy can “remove” cancer risk is not equivalent to clinical evidence; even pages discussing papaya seed claims illustrate why online health information needs careful context. Genetic counselling is about evidence, probabilities and appropriate follow-up, not miracle promises.
Waiting for the result
Results may take several weeks, depending on the laboratory, test type and whether extra analysis is needed. Ask how the result will be delivered and whether you will have a dedicated appointment rather than receiving a short message in an online portal. Waiting can stir up familiar treatment anxiety, so it is reasonable to decide in advance who you want beside you.
A result may be straightforward, but it may also require a second conversation. The counsellor can explain the difference between a gene variant and a diagnosis, and between increased risk and certainty. Even a positive result does not mean a person will definitely develop every cancer associated with that gene.
Privacy is worth discussing in an Australian setting. Ask how the result will be recorded in your medical file, whether it may be visible through My Health Record, and which clinicians can access it. Genetic information can affect relatives as well as the person tested, so confidentiality and family communication should be handled thoughtfully.
Insurance questions also deserve a careful, current answer. Rules and industry policies concerning genetic results and life insurance can change, and they are different from Medicare or private health insurance arrangements. Ask the counsellor what applies now, and obtain independent financial or legal advice before making a major insurance decision based on a result.
What may change afterwards
A pathogenic variant may lead to a tailored screening plan. Depending on the gene and your personal circumstances, this could include more frequent breast imaging, MRI, discussions about risk-reducing surgery, or referrals to gynaecology and other specialists. Your plan should reflect your age, previous surgery, other health conditions and preferences rather than following a one-size-fits-all checklist.
The result may also be relevant to relatives. Adult siblings, parents and children may be offered targeted testing for the specific family variant. Sharing this information can be emotionally complicated: some relatives may want every detail, while others may feel overwhelmed or prefer not to know. A written family letter from the genetics service can make the conversation less personal and easier to begin.
A negative result can still be useful, especially when it rules out a known family variant. However, if no inherited cause is found, your clinicians may continue to base screening on your personal and family history. “No mutation found” is not the same as “no risk”, and a negative panel cannot detect every possible genetic influence.
For survivors managing several appointments, practical access matters as much as the science. Travel from regional New South Wales or northern Queensland, appointment costs, time away from work and referral delays can all shape what is realistic. Broader healthcare access concerns, such as those raised in this discussion of cardiac rehabilitation access, are a useful reminder that a recommendation is only helpful if people can actually reach the service.
Making the appointment feel manageable
Take a support person if you want one, but choose someone who can listen without turning the appointment into a debate. A notebook can help because unfamiliar terms such as “autosomal dominant”, “penetrance” and “cascade testing” are easy to forget. You can also ask permission to record the explanation, or request written information to read later with a cuppa when the medical language feels less intense.
Useful questions include: What is my estimated chance of an inherited variant? Which test are you recommending and why? What would each possible result mean for me? Could the result affect screening or treatment? What should I tell my relatives? How long will testing take, and who will explain the result? Writing these down beforehand can reduce the pressure to remember everything in the room.
Be cautious about direct-to-consumer genetic kits marketed through Australian websites or pharmacies. They may test a limited number of variants, miss changes relevant to your family, or provide findings without the clinical context needed for safe decisions. A medically supervised test through a qualified service is designed around your history rather than a generic sales package.
You also do not have to turn the appointment into a complete emotional reckoning. It is fine to say that you need time, that a topic feels raw, or that you want a referral to a psychologist, breast care nurse or peer-support group. Survivorship is allowed to include humour, merchandise and ordinary pleasures too; the survivor merchandise from My Fabulous Boobies can be a small, visible reminder of community without pretending the experience has been simple.
Genetic counselling is a conversation built around your history, your choices and the limits of current knowledge. Bring what you know, ask what you do not, and remember that a result is information to interpret with a clinical team—not a verdict on your future.